GRACE - Global Resource for Advancing Cancer Education - 4616 25th Ave NE, # 300, Seattle, Washington 98105 - Rated 4.3 based on 15 Reviews "After a...
108 Followers, 115 Following, 53 Posts - See Instagram photos and videos from GRACE (@cancergrace)
Dr. Jack West is a medical oncologist and thoracic oncology specialist, and Executive Director of Employer Services at the City of Hope Comprehensive Cancer Center in Duarte, CA. He is the Founder, and serves as President &CEO of the Global Resource for Advancing Cancer Education (GRACE) and Beacon Medical Interchange, LLC.
Dr. West received an M. Phil. in Experimental Biology from Cambridge University on a Fulbright Scholarship before returning to the US to undertake his medical training at Harvard Medical School in Boston, where he earned his MD magna cum laude and conducted research as a Howard Hughes Medical Student Fellow. He stayed in Boston for his internship and residency in internal medicine at Brigham and Women’s Hospital, then moved to Seattle, Washington for his fellowship in medical oncology at the Fred Hutchinson Cancer Research Center/University of Washington. He moved to the Swedish Cancer Institute in Seattle in late 2002, where he directed the medical oncology component of thoracic oncology program. He moved to City of Hope in March, 2019 to build programs to export subspecialty insights to patients across a broad geography.
Dr. West maintains a strong clinical research focus on lung cancer and has authored dozens of peer-reviewed as well as invited publications. He also serves as Web Editor for JAMA Oncology and a section editor and author for the lung cancer section of UpToDate. Finally, he continues to develop a wide range of novel educational content across many platforms for other physicians, patients, and caregivers through GRACE, Beacon Medical Interchange, and Medscape.
Beacon Medical Interchange is a venture founded in 2016 by Dr. Jack West to facilitate communication of medical experts with industry leaders on the evolution of medical care trends in general and cancer management in particular.
Dr. Jack West interviews Dr. David Spigel of Sarah Cannon Research Institute on the challenges of conducting clinical trials and delivering increasingly complex patient care, along with the possible future role of artificial intelligence and telemedicine. (24:32) Download MP3 Audio Version
President and Founder of OncTalk, LLC (intellectual property transferred to GRACE)
Consultant – AstraZeneca, Eli Lilly, Genentech, GenMab, OSI Pharmaceuticals sanofi-aventis; Center for Biomedical Continuing Education
Speakers Bureau – Eli Lilly, Genentech
Just wanted to give a heads up to people who may be interested that the newest Ken Burns documentary is on the Story of Cancer, and it starts tonight. It'll be running on PBS over 3 nights.
We don't do pop-ups or send lots of messages asking for support, but we do depend on your support to continue to offer our services at no cost. I do everything I do for GRACE with no pay
"CraigInPA" is our beloved and amazingly knowledgeable friend with a ROS1 rearrangement, who is a living testament to how insightful patients can become. He also highlights how patient communities can
Immunotherapy is causing an incredible buzz in the cancer world, so learn more about it in the setting of kidney cancer, melanoma, and lung cancer by coming to our patient forum with the leading
As for the weekly dosing of osimertinib, I've not seen this. We certainly did this for erlotinib 10
It's worth highlighting what is known and what is still unknown here. The role of the
It is important to note that no test is perfectly sensitive at detecting a target all the
I'm sorry to hear about what your wife and you have been going through. This sounds
These approaches haven't been directly compared, and it really depends on who can do the